| Print Friendly |
| Wednesday, December 15, 2004 |
| |
| 8:00 a.m. |
Welcome
William S. Loiry
President & Host
Equity International |
| |
 |
| |
 |
Dr. Diane Berry, Moderator
Senior Advisor
McKenna Long & Aldridge
|
|
|
Colonel Joseph Palma
Medical Director
Chemical and Biological Defense Program
Office of the Secretary of Defense
|
|
|
Dr. Peter Jutro
Deputy Director
National Homeland Security Research Center
Environmental Protection Agency
|
|
| |
|
Dr. Lance Brooks
Scientist, Biological Countermeasures
Office of Programs, Plans, & Budgets
Science & Technology Directorate
Department of Homeland Security |
|
| |
| 9:15 a.m. |
Networking Break |
| |
|
|
| |
Congressional staffers and biodefense experts discuss the ramifications of BioShield I and the possibilities of BioShield II. |
|
|
Frank Rapoport, Moderator
Partner
McKenna Long & Aldridge
|
|
|
Chuck Ludlam
Counsel
Office of Senator Joseph Lieberman
|
|
|
The Honorable Jerome Hauer
Former Acting Assistant Secretary
Office of Public Health Emergency Preparedness
U.S. Department of Health and Human Services
|
|
| |
|
Dr. Stephen S. Morse
Founding Director, Center for Public Health Preparedness
Associate Professor of Clinical Epidemiology
Columbia University
Mailman School of Public Health |
|
| |
|
|
|
| |
Industry prospective on successful business practices in the BioDefense industry. |
|
|
Dan Jacobs, Moderator
Chairman/CEO
The Federal Market Group
|
|
|
Bonnie Ross
Partner
Thompson Ross Associates
|
|
|
John Clerici
Partner
McKenna Long & Aldridge |
|
|
George Lowell
Chief Scientific Officer, BioDefense
ID Biomedical Corporation |
|
| |
| 11:00 a.m. |
Adjournment |
| |
|
| |
*Final Program Subject to Change |
